-
Shanghai Desano and Chongqing Kangfude Partner to Establish Peptide Drug Production Base in China
•
Shanghai Desano Biopharmaceutical Co., Ltd, a leading biopharmaceutical company based in China, has entered into a strategic partnership with Chongqing Kangfude Pharmaceutical Co., Ltd to establish a state-of-the-art peptide drug API and preparation production base in Chongqing. The collaboration involves an investment of RMB 120 million (USD 16.5 million) by…
